Keywords: آنتاگونیست CCR5; HIV; Antiretroviral therapy; Nucleoside/nucleotide reverse transcriptase inhibitors; Non-nucleoside reverse transcriptase inhibitors; Protease inhibitors; Integrase strand transfer inhibitors; Fusion inhibitor; CCR5 antagonist;
مقالات ISI آنتاگونیست CCR5 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Addition of maraviroc to antiretroviral therapy decreased interferon-γ mRNA in the CD4+ T cells of patients with suboptimal CD4+ T-cell recovery
Keywords: آنتاگونیست CCR5; HIV-1; CCR5 antagonist; CD4+ T-cell count; Interferon-γ;
Clinical outcome of maraviroc-containing therapy in heavily pre-treated HIV-1-infected patients
Keywords: آنتاگونیست CCR5; Human immunodeficiency virus; HIV Infection; CCR5 antagonist; Maraviroc; Tropism
Maraviroc reduces neuropathic pain through polarization of microglia and astroglia - Evidence from in vivo and in vitro studies
Keywords: آنتاگونیست CCR5; CCR5 antagonist; Glial “alternative” polarization; Cytokines; Signaling pathways;
Design, synthesis, and biological evaluation of novel 2-methylpiperazine derivatives as potent CCR5 antagonists
Keywords: آنتاگونیست CCR5; CCR5 antagonist; Anti-HIV-1 agent; 2-Methylpiperazine derivatives;
Preferential recognition of monomeric CCR5 expressed in cultured cells by the HIV-1 envelope glycoprotein gp120 for the entry of R5 HIV-1
Keywords: آنتاگونیست CCR5; HIV-1; CCR5; Monomer; Oligomerization; Bimolecular fluorescence complementation assay; CCR5 antagonist;
Development and bioanalytical validation of a liquid chromatographic-tandem mass spectrometric (LC-MS/MS) method for the quantification of the CCR5 antagonist maraviroc in human plasma
Keywords: آنتاگونیست CCR5; Maraviroc; HIV; CCR5 antagonist; Assay validation; LC-MS/MS
Binding of fusion protein FLSC IgG1 to CCR5 is enhanced by CCR5 antagonist Maraviroc
Keywords: آنتاگونیست CCR5; HIV-1; CCR5; CCR5 antagonist; Maraviroc; Fusion protein
Design, syntheses, and characterization of pharmacophore based chemokine receptor CCR5 antagonists as anti prostate cancer agents
Keywords: آنتاگونیست CCR5; Prostate cancer; CCR5 antagonist; Pharmacophore based molecular design
Balancing hERG affinity and absorption in the discovery of AZD5672, an orally active CCR5 antagonist for the treatment of rheumatoid arthritis
Keywords: آنتاگونیست CCR5; CCR5 antagonist; Chemokine receptor; hERG
T-cell changes after a short-term exposure to maraviroc in HIV-infected patients are related to antiviral activity
Keywords: آنتاگونیست CCR5; HIV; Maraviroc; CCR5 antagonist; CD4-positive T-lymphocytes; Viral tropism
Vicriviroc plus optimized background therapy for treatment-experienced subjects with CCR5 HIV-1 infection: Final results of two randomized phase III trials
Keywords: آنتاگونیست CCR5; CCR5 antagonist; Vicriviroc; HIV-1; Treatment-experienced patients
Determination of nifeviroc, a novel CCR5 antagonist: Application to a pharmacokinetic study
Keywords: آنتاگونیست CCR5; Nifeviroc; CCR5 antagonist; LC-ESI-MS/MS; Pharmacokinetics;
Mutational pathways and genetic barriers to CXCR4-mediated entry by human immunodeficiency virus type 1
Keywords: آنتاگونیست CCR5; HIV-1; V3; Coreceptor; Tropism; X4; R5; Dual; CXCR4; CCR5; CCR5 antagonist
Novel hexahydropyrrolo[3,4-c]pyrrole CCR5 antagonists
Keywords: آنتاگونیست CCR5; CCR5 antagonist; Chemokine; Anti-HIV-1; Antiviral
Synthesis, SAR and evaluation of [1,4â²]-bipiperidinyl-4-yl-imidazolidin-2-one derivatives as novel CCR5 antagonists
Keywords: آنتاگونیست CCR5; CCR5 Antagonist; Chemokine; Anti-HIV-1; Antiviral;
Discovery of N-benzyl-N′-(4-pipyridinyl)urea CCR5 antagonists as anti-HIV-1 agents (II): Modification of the acyl portion
Keywords: آنتاگونیست CCR5; CCR5 antagonist; HIV; Urea
Discovery of novel (S)-α-phenyl-γ-amino butanamide containing CCR5 antagonists via functionality inversion approach
Keywords: آنتاگونیست CCR5; CCR5 antagonist; HIV-1 entry inhibitor; Functionality inversion; Bioisostere; Butanamide; Tropane; 2-Methyl-3H-imidazo[4,5-b]pyridine; 3H-[1,2,3]Triazolo[4,5-b]pyridine
Evaluation of amide replacements in CCR5 antagonists as a means to increase intrinsic permeability. Part 2: SAR optimization and pharmacokinetic profile of a homologous azacyle series
Keywords: آنتاگونیست CCR5; CCR5 antagonist; HIV entry inhibition; Permeability
Efficient synthesis and identification of novel propane-1,3-diamino bridged CCR5 antagonists with variation on the basic center carrier
Keywords: آنتاگونیست CCR5; CCR5 antagonist; Propane-1,3-diamine; Convergent synthesis; (S)-β-amino-β-arylpropanal; 4-Amino-4-methylpiperidine; Basic center carrier
Antagonistes du récepteur CCR5Â et infection par le VIH-1Â : bases et conséquences de cette approche thérapeutique
Keywords: آنتاگونیست CCR5; Récepteur de chimiokines; CXCR4; Corécepteur; VIH-1; Coactivation; Traitement antirétroviral; Antagoniste CCR5; Chemokine receptor; CXCR4; Coreceptor; HIV-1; Coactivation; Antiretroviral therapy; CCR5 antagonist;
Drugs for HIV: strategies for use
Keywords: آنتاگونیست CCR5; antiretroviral; CCR5 antagonist; HIV; integrase inhibitor; nucleoside reverse transcriptase inhibitor (NRTI); non-nucleoside reverse transcriptase inhibitor (NNRTI); protease inhibitor
Discovery of a potent, selective and orally bioavailable 3,9-diazaspiro[5.5]undeca-2-one CCR5 antagonist
Keywords: آنتاگونیست CCR5; CCR5 antagonist; 3,9-Diazaspiro[5.5]undecane; 3,9-Diazaspiro[5.5]undecan-2-one; Anti-HIV-1
Spiropiperidine CCR5 antagonists
Keywords: آنتاگونیست CCR5; CCR5 antagonist; Chemokine; Anti-HIV-1; Antiviral; Spiropiperidine
Les antagonistes du récepteur CCR5 : une nouvelle classe d'antirétroviraux
Keywords: آنتاگونیست CCR5; antagoniste de CCR5; maraviroc; vicriviroc; tropisme; VIH; CCR5 antagonist; HIV; maraviroc; vicriviroc; tropism;
Anti-HIV-1 entry optimization of novel imidazopiperidine-tropane CCR5 antagonists
Keywords: آنتاگونیست CCR5; CCR5; Chemokine receptor; CCR5 antagonist; HIV-1 entry; Viral entry; Entry inhibitor
Modulators of the human CCR5 receptor. Part 3: SAR of substituted 1-[3-(4-methanesulfonylphenyl)-3-phenylpropyl]-piperidinyl phenylacetamides
Keywords: آنتاگونیست CCR5; CCR5 modulator; CCR5 antagonist; Chemokine receptor; CCR5
Unusual asymmetric oxidation of sulfide; the diastereoselective oxidation of prochiral sulfide-chiral acid salt with hydrogen peroxide without metal
Keywords: آنتاگونیست CCR5; Diastereoselective sulfoxidation; Benzazepine; CCR5 antagonist;
Synthesis and evaluation of CCR5 antagonists containing modified 4-piperidinyl-2-phenyl-1-(phenylsulfonylamino)-butane
Keywords: آنتاگونیست CCR5; CCR5 antagonist; Anti-HIV; Piperidine;
An improved synthesis of piperazino-piperidine based CCR5 antagonists with flexible variation on pharmacophore sites
Keywords: آنتاگونیست CCR5; Piperazino-piperidine nucleus; CCR5 antagonist; Reductive amination; Chiral pool; 4-Substituent-4-aminopiperidine;
CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological evaluation of piperidine-4-carboxamide derivatives
Keywords: آنتاگونیست CCR5; CCR5 antagonist; Chemokine; HIV-1; Piperidine-4-carboxamide;
Orally active CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological activities of 1-benzazepine derivatives containing a sulfoxide moiety
Keywords: آنتاگونیست CCR5; CCR5 antagonist; HIV-1; Sulfoxide; S-isomer; 1-Benzazepine;